ESMO 2017 | The current state of drug development against sarcomas
Robin Jones, BSc, MB BS, MRCP, MD (Res), from The Royal Marsden NHS Foundation Trust, London, UK talks to us about the sessions presented at the 2017 European Society for Medical Oncology (ESMO) conference which focused on the current state of research into sarcoma treatments. Dr Jones explains the main message he took away from these presentations, and talks us through some of the ongoing work into sarcoma treatment, including trials to investigate the agents BLU-285 (NCT02508532), DCC-2618 (NCT02571036) and crenolanib (NCT02847429). This interview was recorded at ESMO 2017 in Madrid, Spain.
Get great new content delivered to your inboxSign up